Lars Svennerholm

Lars Svennerholm's AcademicInfluence.com Rankings

Lars Svennerholm

Biology

#2025

World Rank

#3265

Historical Rank

Neuroscience

#158

World Rank

#167

Historical Rank

Biochemistry

#151

World Rank

#193

Historical Rank

biology Degrees

Lars Svennerholm

Philosophy

#1927

World Rank

#3391

Historical Rank

Logic

#363

World Rank

#706

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Lars Svennerholm's Degrees

PhD Medicine University of Gothenburg

Why Is Lars Svennerholm Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lars Svennerholm's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. (1957) (2512)
CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * (1963) (1476)
A procedure for the quantitative isolation of brain gangliosides. (1980) (680)
THE QUANTITATIVE ESTIMATION OF CEREBROSIDES IN NERVOUS TISSUE (1956) (511)
Tissue Receptor for Cholera Exotoxin: Postulated Structure from Studies with GM1 Ganglioside and Related Glycolipids (1973) (421)
Quantitative Estimation of Sialic Acids. III. An Anion Exchange Resin Method. (1958) (330)
Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. (1975) (324)
Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) (1994) (323)
Biochemical changes in Dementia disorders of Alzheimer type (AD/SDAT) (1983) (305)
SEASONAL AND CIRCADIAN MONOAMINE VARIATIONS IN HUMAN BRAINS EXAMINED POST MORTEM (1980) (301)
Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. (1980) (282)
Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. (1977) (282)
Human brain gangliosides: developmental changes from early fetal stage to advanced age. (1989) (270)
DEVELOPMENTAL PROFILES OF GANGLIOSIDES IN HUMAN AND RAT BRAIN (1971) (265)
Accumulation of Glucosylceramide and Glucosylsphingosine (Psychosine) in Cerebrum and Cerebellum in Infantile and Juvenile Gaucher Disease (1982) (253)
Specific gangliosides function as host cell receptors for Sendai virus. (1981) (250)
Membrane Lipids of Adult Human Brain: Lipid Composition of Frontal and Temporal Lobe in Subjects of Age 20 to 100 Years (1994) (244)
THE DISTRIBUTION OF LIPIDS IN THE HUMAN NERVOUS SYSTEM—I (1964) (193)
COMPOSITION OF GANGLIOSIDES AND PHOSPHOLIPIDS OF NEURONAL AND GLIAL CELL ENRICHED FRACTIONS 1 (1971) (191)
Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. (1983) (188)
Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes (1997) (184)
Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors (1990) (180)
Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. (1994) (179)
The chemical structure of normal human brain and Tay-Sachs gangliosides. (1962) (178)
Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. (1993) (169)
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. (1980) (163)
The distribution of lipids in the human nervous system. II. Lipid composition of human fetal and infant brain. (1972) (147)
Quantitative Paper Partition Chromatography of Sialic Acids (1958) (146)
Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin (1982) (144)
Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. (1984) (141)
Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain. (1973) (141)
A double‐blind evaluation of electroconvulsive therapy in Parkinson's disease with “on‐off” phenomena (1987) (134)
Gangliosides and synaptic transmission. (1980) (129)
Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody (1985) (125)
Gangliosides of human, bovine and rabbit retina. (1972) (123)
Separation of gangliosides on a new type of anion-exchange resin. (1980) (123)
CSF Monoamines in Autistic Syndromes and Other Pervasive Developmental Disorders of Early Childhood (1987) (122)
Ganglioside designation. (1980) (116)
Structure and Function of Gangliosides (1980) (116)
Polystyrene-adsorbed gangliosides for investigation of the structure of the tetanus-toxin receptor. (1980) (114)
Characterization of the binding epitope of a monoclonal antibody to sulphatide. (1988) (114)
Designation and schematic structure of gangliosides and allied glycosphingolipids. (1994) (114)
Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. (1985) (109)
Membrane Lipids in the Aging Human Brain (1991) (109)
Alzheimer Disease – Effect of Continuous Intracerebroventricular Treatment with GM1 Ganglioside and a Systematic Activation Programme (2002) (107)
THE SEPARATION OF NEUTRAL BLOOD-SERUM GLYCOLIPIDS BY THIN-LAYER CHROMATOGRAPHY. (1963) (106)
Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides. (1980) (106)
The Isolation of Chondrosamine from Gangliosides and from Submaxillary Mucin. (1952) (106)
Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma. (1985) (106)
FATTY ACID COMPOSITION OF PLASMA AND RED CELL PHOSPHOGLYCERIDES IN FULL TERM INFANTS AND THEIR MOTHERS 1 (1970) (105)
Structure of the major glucosamine-containing ganglioside of human tissues. (1973) (97)
Blood brain barrier function in vascular dementia (1990) (96)
Fixation and inactivation of cholera toxin by GM1 ganglioside. (1973) (96)
LONG‐TERM FOLLOW‐UP OF THE FIRST SUCCESSFUL BONE MARROW TRANSPLANTATION IN GAUCHER DISEASE (1988) (91)
Continuous Culture Studies on Glycogen Synthesis in Escherichia coli B. (1957) (91)
Childhood psychosis and monoamine metabolites in spinal fluid (1983) (91)
Gangliosides--a new therapeutic agent against stroke and Alzheimer's disease. (1994) (88)
Decreased myelin lipids in Alzheimer's disease and vascular dementia (1989) (87)
Sphingolipids of human skeletal muscle (1972) (86)
The Molecular Weight of Myeloperoxidase. (1958) (86)
Neurotransmitter deficits in a non‐multi‐infarct category of vascular dementia (1989) (85)
Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type (1996) (83)
Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. (1993) (82)
The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease. (1982) (80)
Protein Analysis in Cerebrospinal Fluid (1993) (80)
Diagnosis of Krabbe's infantile leucodystrophy (1963) (80)
Neuropathology of the Norrbottnian type of Gaucher disease (1984) (78)
Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system. (1987) (77)
Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'. (1991) (76)
Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1. (1986) (76)
Lipid alterations in apparently normal white matter in multiple sclerosis. (1971) (75)
Composition of Gangliosides from Human Brain (1956) (75)
Membrane lipids of human peripheral nerve and spinal cord. (1992) (74)
THE DISTRIBUTION OF LIPIDS IN THE HUMAN NERVOUS SYSTEM‐V. GANGLIOSIDES AND ALLIED NEUTRAL GLYCOLIPIDS OF INFANT BRAIN (1973) (73)
Gangliosides as receptors for bacterial toxins and Sendai virus. (1980) (73)
Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside. (1981) (72)
Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age (1993) (71)
Crystalline Animal Alcohol Dehydrogenase. 2. (1950) (70)
Rett syndrome: biogenic amines and metabolites in postmortem brain. (1989) (70)
Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line (1986) (69)
Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. (1991) (67)
The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. (1979) (66)
Characterization and quantitative determination of gangliosides and neutral glycosphingolipids in human liver. (1982) (65)
Low B12 levels related to high activity of platelet MAO in patients with dementia disorders (1988) (65)
[66] Sialic acids and derivatives: Estimation by the ion-exchange method (1963) (65)
Absence of hexosaminidase A and B in a normal adult. (1975) (64)
Sialic acids in blood serum. (1958) (63)
Gangliosides in Human Fetal Brain (1991) (62)
A sulfated glucosylceramide from rat kidney. (1989) (62)
LATE INFANTILE PROGRESSIVE ENCEPHALOPATHY WITH DISTURBED POLYUNSATURATED FAT METABOLISM (1968) (61)
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease (1992) (61)
CHEMICAL PATHOLOGY OF KRABBE'S DISEASE (1975) (60)
Trisialosyllactosylceramide (GT3) is a ganglioside of human lung (1986) (59)
Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. (1986) (59)
Sialyllactotetraosylceramide, a Ganglioside Marker for Human Malignant Gliomas (1988) (58)
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia (1992) (58)
Neutral Glycolipids of Human Blood Serum, Spleen and Liver (1963) (58)
The distribution of lipids in the human nervous system. 3. Fatty acid composition of phosphoglycerides of human foetal and infant brain. (1973) (57)
Effect of maternal essential fatty acid supply on fatty acid composition of brain, liver, muscle and serum in 21-day-old rats. (1972) (57)
Large Alterations in Ganglioside and Neutral Glycosphingolipid Patterns in Brains from Cases with Infantile Neuronal Ceroid Lipofuscinosis/Polyunsaturated Fatty Acid Lipidosis (1987) (57)
Late Infantile Metachromatic Leucodystrophy of the Genetic Type (1960) (56)
The determination of hexosamines with special reference to nervous tissue. (1957) (55)
Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin (1991) (55)
Chemical pathology of Krabbe disease: the occurrence of psychosine and other neutral sphingoglycolipids. (1976) (54)
THE EFFECT OF DIFFERENT DIETARY LEVELS OF ESSENTIAL FATTY ACIDS ON LIPIDS OF RAT CEREBRUM DURING MATURATION 1 (1974) (54)
CHANGES IN FATTY ACID COMPOSITION OF HUMAN BRAIN MYELIN LIPIDS DURING MATURATION 1 (1978) (54)
Sulfatide lipidosis in childhood. Report of a case investigated during life and at autopsy. (1962) (53)
Lysosulfatide (Galactosylsphingosine‐3‐O‐Sulfate) from Metachromatic Leukodystrophy and Normal Human Brain (1989) (52)
Enzyme replacement therapy of infantile Gaucher disease. (1993) (52)
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. (1985) (52)
CONCENTRATION AND FATTY ACID COMPOSITION OF CHOLESTERYL ESTERS OF NORMAL HUMAN BRAIN 1 (1969) (52)
Potential ganglioside antigens associated with human gliomas. (1986) (50)
Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients. (1997) (49)
PURIFICATION AND CHEMICAL ANALYSIS OF THE ERYTHROCYTE RECEPTOR FOR HEMAGGLUTINATING ENTEROVIRUSES. (1964) (49)
Barium Hydroxide as a Selective Precipitating Agent for Hemicelluloses. (1958) (48)
The Lipids of a Lysozyme Sensitive Bacillus Species (Bacillus "M"). (1957) (48)
Clinical and Biochemical Outcome of Marrow Transplantation for Gaucher Disease of the Norrbottnian Type (1990) (48)
The Crystal Structure of Mo5SiB2. (1958) (48)
BIOSYNTHESIS AND BIODEGRADATION OF RAT BRAIN GANGLIOSIDES STUDIED IN VIVO (1972) (48)
Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid (1993) (46)
Isolation of Gangliosides. (1963) (46)
CSF and urine biogenic amine metabolites in Rett syndrome (1990) (46)
Expression of Gangliosides GD3 and 3′‐isoLM1 in Autopsy Brains from Patients with Malignant Tumors (1993) (45)
Splenic transplantation in a case of Gaucher's disease. (1971) (45)
Receptor ganglioside content of three hosts for Sendai virus. MDBK, HeLa, and MDCK cells. (1984) (44)
Ganglioside Composition in Human Meningiomas (1989) (44)
Cerebral dysfunction in fibromyalgia: evidence from regional cerebral blood flow measurements, otoneurological tests and cerebrospinal fluid analysis (1995) (43)
Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants (1985) (41)
Quantitative isolation of brain sulfatides (1962) (41)
Chloroquine Intoxication Induces Ganglioside Storage in Nervous Tissue: A Chemical and Histopathological Study of Brain, Spinal Cord, Dorsal Root Ganglia, and Retina in the Miniature Pig (1981) (39)
CHEMICAL PATHOLOGY OF KRABBE'S DISEASE (1975) (39)
Ubiquitin in Cerebrospinal Fluid in Alzheimer's Disease and Vascular Dementia (1994) (39)
Kidney Glycolipids in Late Infantile Metachromatic Leucodystrophy (1966) (39)
Parenteral administration of GM1 ganglioside to presenile Alzheimer patients (1990) (39)
Antibodies in the CSF of a Parkinson patient recognizes neurons in rat mesencephalic regions. (1986) (39)
Tissue receptor for cholera exotoxin: structural requirements of G11 ganglioside in toxin binding and inactivation. (1974) (38)
Composition of brain gangliosides (1961) (38)
Binding specificity of monoclonal antibodies to ganglioside, Fuc-GM1. (1986) (38)
EFFECTS OF DIET ON FATTY ACID COMPOSITION OF PLASMA AND RED CELL PHOSPHOGLYCERIDES IN THREE‐MONTH‐OLD INFANTS (1971) (38)
THE METABOLISM OF GANGLIOSIDES IN CEREBRAL LIPIDOSES (1967) (38)
Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats. (1990) (38)
Gangliosides of human meconium ‐ detection of a possible fetal antigen (1981) (36)
Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas (1991) (36)
Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations. (1982) (35)
Monoclonal antibodies raised against NeuAc alpha 2-6neolactotetraosylceramide detect carcinoma-associated gangliosides. (1985) (35)
Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings (2004) (34)
Essential fatty acids in chronic alcoholism. (1979) (34)
Metachromatic Leucodystrophy—a Generalized Lipidosis Determination of Sulfatides in Urine, Blood Plasma and Cerebrospinal Fluid (1960) (34)
Bone marrow transplantation for metabolic disorders at Huddinge Hospital. (1990) (34)
POLYUNSATURATED FATTY ACID LIPIDOSIS (1975) (34)
Formulas for the quantitation of intrathecal IgG production Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis (1994) (34)
Rapidly Progressive Type III Gaucher Disease: Deterioration Following Partial Splenectomy (1990) (33)
BINDING OF INTRALUMINAL TOXIN IN CHOLERA: TRIAL OF GM1 GANGLIOSIDE CHARCOAL (1980) (33)
Tay‐Sachs Disease (1966) (33)
The fatty acid composition of placenta in intrauterine growth retardation. (1991) (32)
Serum fatty acid pattern in chronic alcoholics after acute abuse. (2009) (32)
Isolation of "kepalin B" from cerebral lipids. (1960) (32)
Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. (1989) (32)
Differences in cerebrospinal fluid gangliosides between “probable Alzheimer’s disease” and normal aging (1992) (32)
On the Antifungal Effect of Benzoxazolinone and 6-Methoxybenzoxazolinone, Respectively, on Fusarium nivale. (1958) (31)
Separation of gangliosides by anion-exchange chromatography on Mono Q. (1985) (31)
Lipid and fatty acid composition of human cerebral myelin during development. (1978) (31)
Isolation of the Major Ganglioside of Human Spleen. (1963) (31)
The distribution of lipids in the human nervous system. IV. Fatty acid composition of major sphingolipids of human infant brain. (1973) (31)
Membrane cerebral lipids in Rett syndrome. (1991) (31)
Salla disease variants. Sialoylaciduric encephalopathy with increased sialidase activity in two non-Finnish children. (1986) (30)
Gangliosides and other glycolipids of human placenta. (1965) (30)
Niemann‐Pick Disease in Infancy (1963) (30)
Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography‐mass spectrometry (1987) (30)
Interaction of cholera toxin and ganglioside G(M1). (1976) (29)
Chemical structures of three fucogangliosides isolated from nervous tissue of mini-pig. (1981) (28)
The effect of different dietary levels of essential fatty acids on growth of the rat. (1974) (28)
Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease (1990) (28)
Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation. (1991) (28)
BIOCHEMICAL DEVELOPMENT OF RAT FOREBRAINS IN SEVERE PROTEIN AND ESSENTIAL FATTY ACID DEFICIENCIES (1978) (28)
Expression of gangliosides as receptors at the cell surface controls infection of NCTC 2071 cells by Sendai virus. (1986) (27)
Isolation of 32P-labeled Phosphoserine from a Preparation of Intestinal Alkaline Phosphatase Incubated with Radioactive Inorganic Phosphate. (1958) (27)
Skeletal muscle lipids. I. Changes in fatty acid composition of lecithin in man during growth. (1971) (27)
Plasma Total Lipid, Cholesterol, Triglycerides, Phospholipids and Free Fatty Acids in a Healthy Scandinavian Population (2009) (26)
Hypothalamic monoamines and neuropeptides in dementia (1991) (26)
Blood Level of Cerebrosides in Gaucher's Disease1 (1960) (26)
Production and characterization of two human glioma xenograft-localizing monoclonal antibodies. (1986) (26)
Quantitative estimation of gangliosides in senile human brains. (1957) (26)
Determination of Gangliosides in Six Human Primary Medulloblastomas (1990) (26)
Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. (1991) (25)
Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo. (1993) (25)
Effect of chloroquine on the activity of some lysosomal enzymes involved in ganglioside degradation. (1987) (25)
THE ACTIVITY OF GANGLIOSIDE SIALIDASE IN THE DEVELOPING HUMAN BRAIN (1971) (24)
Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients (2005) (24)
Gangliosides and sulphatide in human cerebrospinal fluid: quantitation with immunoaffinity techniques. (1989) (24)
Gangliosides in serum immune complexes from tumor-bearing patients. (1985) (24)
On the isolation and characterization of N-acetyl-sialic acid. (1956) (23)
MALIGNANT HYPERLIPEMIA IN INFANCY. (1964) (23)
MAJOR PLASMA LIPIDS AND THEIR FATTY ACID COMPOSITION IN MULTIPLE SCLEROSIS AND OTHER NEUROLOGICAL DISEASES (1971) (23)
Use of leukocytes in diagnosis of Krabbe disease and detection of carriers. (1981) (23)
Ganglioside loss is a primary event in Alzheimer disease type I. (1994) (23)
Chondrosamine as a Component of Gangliosides and of Submaxillary Mucin. (1950) (23)
Structure of a Glyceritol Glycoside from Polysiphonia fastigiata and Corallina officinalis. (1958) (23)
Chemical differentiation of the Gaucher subtypes. (1982) (22)
On Sialic Acid in Brain Tissue. (1956) (22)
A new ganglioside of the lactotetraose series, GalNAc-3'-isoLM1, detected in human meconium. (1989) (22)
Structure and Biology of Cell Membrane Gangliosides (1980) (22)
Chloroquine-induced accumulation of gangliosides and phospholipids in skeletal muscles. Quantitative determination and characterization of stored lipids. (1981) (22)
Expression of the Ganglioside GD3 in Human Meningiomas Is Associated with Monosomy of Chromosome 22 (1990) (21)
ATTEMPT AT ENZYME REPLACEMENT IN GAUCHER DISEASE BY RENAL TRANSPLANTATION (1979) (21)
The content of carbohydrates in caseins from different species. (1956) (21)
Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies. (1994) (21)
BONE MARROW TRANSPLANTATION IN THE NORRBOTTNIAN FORM OF GAUCHER DISEASE (1984) (21)
Late onset globoid cell leukodystrophy (Krabbe's disease)– Swedish case with 15 years of follow‐up (1995) (21)
Lipid pattern and fatty acid composition of human palatal oral epithelium. (1977) (20)
Gangliosides and neutral glycosphingolipids of normal tissue and oat cell carcinoma of human lung. (1986) (20)
Gangliosides in children with autism (1995) (20)
The Acid-soluble Nucleotides of Barley and Oat Plants. (1957) (20)
Sialosyllactotetraosylceramide, 3′‐isoLM1, a Ganglioside of the Lactotetraose Series Isolated from Normal Human Infant Brain (1987) (20)
A monoclonal antibody reacting specifically with ganglioside GD1b in human brain (1985) (19)
Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. (1983) (19)
Neurovisceral storage disorder simulating Niemann-Pick disease. A new form of oligosaccharidosis? (1978) (19)
On the Biosynthesis of Recently Discovered Derivatives of Glutamic Acid in Plants. (1958) (19)
Isolation of complex gangliosides from human brain. (1992) (19)
Clinical and Laboratory Diagnosis of Metachromatic Leucodystrophy (1961) (18)
CEREBROSPINAL FLUID γ‐GLOBULINS IN SUBACUTE SCLEROSING LEUCOENCEPHALITIS (1968) (18)
On the Crystal Structure of POCl3.SbCl5. (1958) (18)
Brain Gangliosides in Krabbe Disease (1972) (18)
High-performance liquid chromatographic separation of gangliosides, combined with immunological detection and fast atom bombardment mass spectrometric characterization. (1989) (18)
The structure of the tetrasialoganglioside from human brain (1980) (17)
Relationship between DST and the serotonergic system. Results from treatments with two 5‐HT reuptake blockers in dementia disorders (1988) (17)
Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2. (1990) (17)
Concentration, composition and structure of gangliosides from the central nervous systems of dogfish, Squalus acanthia, and cod, Gadus callarias. (1982) (17)
[86] – Gangliosides, Isolation (1972) (16)
Galactosyltransferases catalyzing the formation of the galactosyl-galactosyl linkage in glycosphingolipids. (1974) (16)
N-Terminal Amino Acids of Human and Bovine Prothrombin. (1958) (16)
Prenatal diagnosis of Krabbe disease (1981) (16)
The Excretion of Urinary Sulfatides in Health and Neurological Disease (1965) (16)
The use of galactosylceramides with uniform fatty acids as substrates in the diagnosis and carrier detection of Krabbe disease. (1982) (16)
Prenatal diagnosis of Gaucher disease Assay of the ß‐glucosidase activity in amniotic fluid cells cultivated in two laboratories with different cultivation conditions (1981) (15)
The Magnetic Properties of [Co-(NH3)5(NO)]Cl2 (black) and [Co(NH3)5(NO)](NO3)2.½H2O (red). Studies in Magnetochemistry 21. (1958) (15)
Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro (1994) (15)
Deleted ring chromosome 22 in a mentally retarded boy (1986) (15)
The Reaction between Phenols and Orthoesters. A New Synthesis of Aryl Alkyl Ethers. (1956) (15)
Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production. (1993) (14)
Neurochemical Changes in White Matter of Patients with Alzheimer’s Disease (1987) (14)
Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease. (1980) (14)
Lipid accumulation in liver, spleen, lungs and kidneys of miniature-pigs after chloroquine treatment. (1982) (14)
Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope (1993) (14)
Fatty acid composition of serum cholesteryl ester fractions isolated by thin-layer chromatography. (1968) (14)
Molecular neuropathology. (1976) (13)
Isolation of Sialic Acid from Brain Gangliosides. (1955) (13)
4. Identification of the accumulated ganglioside (2001) (13)
Isolation of Blood Serum Glycolipids. (1962) (13)
Specific Gangliosides are Receptors for Sendai Virus (1984) (13)
Monoclonal antibodies to malignant human gliomas. (1992) (13)
Colorectal carcinomas have a characteristic ganglioside pattern. (1983) (13)
Experimental studies on the pathogenesis of leucodystrophies I. The effect of intracerebrally injected sphingolipids in the rat's brain (1966) (13)
Tay-Sachs disease. A generalized metabolic disorder. (1966) (12)
Recommendations for Clinical Drug Trials in Dementia (1990) (12)
Protein-bound Sialic Acids in Human, Hog, and Horse Kidneys. (1957) (12)
Chromatographic Determination of Sulfatides. (1963) (12)
Quantitative estimation of cerebrosides in plasma. (1958) (12)
CLINICAL PROFILE AND PAPER‐ELECTRO‐PHORESIS IN MULTIPLE SCLEROSIS (1964) (12)
Glycolipids and glycosyltransferases in permanent cell lines established from human medulloblastomas. (1991) (12)
Sulphatide lipidosis in the adult with the clinical picture of progressive organic dementia with epileptic seizures (2004) (12)
Isolation of N-acetylsialic acid from normal liver. (1957) (12)
The Influence of Anharmonicity upon the Vibrational Probability Density and Mean Amplitudes in Diatomic Molecules. (1958) (11)
Gangliosides of human thyroid gland. (1985) (11)
Pyrazole Studies. XI. Oxidation by Air of 1:4-Disubstituted Pyrazolidine-3:5-diones. (1958) (11)
Action of Group Blocking Agents and Enzymes on Intrinsic Factor Preparations. (1958) (11)
Fatty acid profiles of cerebrospinal fluid lipids in normals and chronic alcoholics. (1970) (11)
Alaproclate: A pharmacokinetic and biochemical study in patients with dementia of Alzheimer type (2004) (11)
Differences in Carbohydrate Content between Caseins from Cow's and Human Milk. (1955) (11)
The Sialic Acids of Hog Gastric Mucosa. (1958) (11)
Biogenic Amines and Related Enzymes in Normal Aging, Senile Dementia and Chronic Alcoholism (1981) (11)
Glycoprotein pattern in human brain tumors studied using lectin binding after sodium dodecyl sulfate-gel electrophoresis and protein blotting (1987) (10)
Altered cerebellar ganglioside pattern in rett syndrome (1991) (10)
Essential fatty acid status is altered in pregnancies complicated by intrauterine growth retardation. (1994) (10)
Intrathecal synthesis of immunoglobulin G in vascular dementia (1990) (10)
On the Reactions in Solutions of Phosphorus Oxychloride. (1958) (10)
Fucosyl-GM1 — A ganglioside associated with small cell lung carcinomas (1984) (10)
Reductions in Membrane Proteins and Lipids in Basal Ganglia of Classic Alzheimer Disease Patients (1996) (10)
Immunoassays based on plastic-adsorbed gangliosides. (1980) (9)
Effect of Different Dietary Levels of Essential Fatty Acids on Liver and Serum Lipids in the Rat (1976) (9)
[65] Sialic acids and derivatives: Preparation (1963) (9)
Fractionation of the Lipides of Eye Lenses by Gradient Elution on Activated Silicic Acid Columns. (1958) (9)
The sialic acids of hog pancreas. (1958) (9)
Ganglioside GM1 metabolism in living human fibroblasts with β-galactosidase deficiency (1986) (9)
Cerebrospinal fluid gangliosides in patients with Rett syndrome and infantile neuronal ceroid lipofuscinosis. (1999) (9)
Experimental studies on the pathogenesis of leucodystrophies (1966) (9)
Infantile amaurotic idiocy; microscopical and chemical investigation of one case. (2009) (9)
Effects on offspring of maternal malnutrition in the rat. In: lipids, malnutrition & the developing brain. (2008) (9)
The diagnosis of Tay-Sachs disease. (1971) (8)
Specific gangliosides are receptors for Sendai virus. Proteins in lipid samples can mask positive biological effects. (1984) (8)
Attempt at enzyme replacement by organ transplantation: renal transplantation in Gaucher disease. (1979) (8)
The effect of different dietary levels of essential fatty acids on body composition of the rat. (1974) (8)
The clonidine test in patients with dementia disorders: Relation to clinical status and cerebrospinal fluid metabolite levels (1988) (8)
Partition Chromatography of Brain Gangliosides on Cellulose (1954) (8)
Structure of a Solvate of Barium Pentathionate with Acetone. (1958) (7)
On the Presence of Nucleoproteins and Lipoproteins in the Salt-soluble Protein Fraction of Barley. (1957) (7)
Histological and chemical studies of a case of phenylketonuria with long survival. (2008) (7)
Gangliosides as Receptors for Cholera Toxin, Tetanus Toxin, and Sendai Virus (1980) (7)
Further in vivo studies on the biosynthetic relationship between the major brain gangliosides in rat (1974) (7)
Biological function of gangliosides : proceedings of Nobel Symposium 83 (1994) (7)
The Crystal and Molecular Structure of Ethylene Thiocyanate. (1958) (7)
Hematological findings in the Norrbottnian type of Gaucher disease (1982) (7)
Clinical, morphological, and biochemical investigations on a patient with an unusual form of neuronal ceroid-lipofuscinosis (1979) (7)
Reduced glomerular filtration rate in a lithium-treated bipolar patient with primary hypothyroidism--reversal by levothyroxine. (1988) (7)
Splenic transplantation in Gaucher disease. (1973) (7)
Cholelithiasis in childhood. A follow-up study with special reference to heredity, constitutional factors and serum lipids. (1962) (7)
Cerebroside‐β‐glucosidase activity in Gaucher brain (1986) (6)
Chemical pathology of krabbe's disease. IV. Studies of galactosylceramide and lactosylceramide BETA-galactosidases in brain, white blood cells and aminotic fluid cells. (1975) (6)
PROPOSED STANDARDIZATION OF ANALYSIS OF CEREBROSPINAL FLUID PROTEINS (1964) (6)
On the Isolation of Gangliosides. (1956) (6)
Neurochemical Changes in Brains from Patients with Vascular Dementia (1991) (6)
On the Reactions and Biosynthesis of Azetidine-2-carboxylic Acid. (1958) (6)
Gangliosides in the nervous system (1983) (6)
THE DIAGNOSIS OF TAY‐SACHS DISEASE1 (1971) (6)
Cis- and Trans-2,5-Dimethoxy-2,5-Dihydrofuran. (1958) (5)
Occurrence in Plaice Myogen of a Low Molecular Weight Protein of Abnormal Amino Acid Composition. (1958) (5)
The Quantitative Determination of 2(3)-Benzoxazolinone from Rye Seedlings. (1958) (5)
Gangliosides of human intestinal mucosa: detection of a possible fetal antigen. (1982) (5)
Cerebrospinal Fluid Cytology in Alzheimer's Disease (1991) (5)
Investigation of Intrathecal Synthesis of Immunoglobulin G in Primary Degenerative Dementia (Alzheimer's Disease) (1991) (5)
Circulating glycoconjugates in CSF of meningioma patients (1990) (5)
In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line (1996) (5)
Chronic sclerosing panencephalitis (2004) (4)
SERUM-LIPIDS IN CHRONIC ALCOHOLICS (1967) (4)
Anomalous Reactions of 2-Naphthylmethylmagnesium Bromide. (1958) (4)
White Matter Gangliosides in Incomplete Infarction (1990) (4)
Attempt at enzyme replacement in Gaucher disease by renal transplantation. (1980) (4)
The Photochemical Reaction between Nitric Oxide and Isopropanol, Sensitized by Benzophenone. (1958) (4)
Identification of the accumulated ganglioside. (2001) (4)
Ganglioside characterization of rat astroglial cells in primary culture: Detection of the ganglio and lacto series gangliosides (1991) (4)
Quantitative Determination of Bile Acids in Bile. (1955) (4)
Gangliosides in human palatal oral epithelium. (1979) (4)
[Lipid and fatty acid composition of nervous tissue phosphoglycerides of squid, lobster, dogfish and cod]. (1973) (4)
A Note on the Isolation of Solamargine from Solanum nigrum. (1958) (4)
Assay of the β‐glucosidase activity with natural labelled and artificial substrates in cultivated skin fibroblasts from homozygotes and heterozygotes with the Norrbottnian type of Gaucher disease (1980) (4)
Cerebroside-beta-glucosidase activity in Gaucher brain. (1986) (3)
Monoclonal Antibodies Against Gangliosides (1987) (3)
CHEMICAL PATHOLOGY OF KRABBE'S DISEASE II. Futty Acid Composition of Cerebrosides, Sulfatides and Sphingomyrlins in Brain (1974) (3)
Chemical and immunological characterisation of the major glucosamine-containing ganglioside of human tissues. (1974) (3)
Which glycolipids are the autoantigens of cytoplasmatic islet cell antibodies? (1992) (3)
Effect of different dietary levels of essential fatty acids on the fatty acid composition of lecithin in rat skeletal muscle. (1974) (3)
Chronic sclerosing panencephalitis (2004) (3)
Simple Proof of the Ergodic Theorem (1958) (3)
Clinical and laboratory diagnosis of metachromaticleucodystrophy. (1961) (3)
Biochemistry of the neurolipids. (1990) (3)
Partition Chromatography of some C27-Steroids. (1956) (2)
Serum fatty acid patterns in hereditary motor and sensory neuropathies. (1981) (2)
Pyrazole Studies. XII. Hydrazobenzene-catalysed Oxidation of 1:2-Diphenyl-4-butylpyrazolidine-3,5-dione (Butazolidine). (1958) (2)
Panel discussion of ‘proposed standardization of analysis of cerebrospinal fluid proteins' (1965) (2)
A Simple Apparatus for Making Holes in Agar Plates (1958) (2)
Malignant hyperlipaemia in infants: another inborn error of metabolism? (1961) (2)
The Crystal Structure of Monoclinic Barium Telluropentathionate Dihydrate. (1958) (2)
Chapter 36 – GLYCOLIPIDS AND OTHER AMINO SUGAR–CONTAINING COMPOUNDS IN THE NERVOUS SYSTEM (1965) (2)
N-Terminal Amino Acids of Human Pituitary Growth Hormone. (1958) (2)
Diagnosis of the sphingolipidoses with labelled natural substrates. (1978) (2)
Ganglioside mapping of a human medulloblastoma xenograft (2004) (2)
On Some Unknown Metabolic Intermediates in Plants. (1958) (2)
The Composition of Ribonucleic Acids Isolated from Chloroplasts of Lamium album and Symphytum officinale. (1957) (2)
Metabolic Changes Following Splenic Transplantation in a Case of Gaucher’s Disease (1972) (2)
The Anticoagulant Effect of Brain Gangliosides. (1955) (2)
Human glioma-associated gangliosides for monoclonal antibody production (1985) (1)
DISTRIBUTION OF GANGLIOSIDE GD3 IN CULTURED HUMAN TUMOR CELLS OF NEUROECTODERMAL ORIGIN AS DEFINED BY ANTI-GD3 MONOCLONAL ANTIBODIES: 12 (1989) (1)
Polyunsaturated fatty acid lipidosis infantile form of so-called neuronal ceroidlipofuscinosis. (1974) (1)
Classification of lipidoses. (1970) (1)
Detection bymonoclonal antibody ofcarbohydrate antigen CA 50inserumofpatients withcarcinoma (1984) (1)
8. Gangliosides and nerve growth factors in Alzheimer's disease (1990) (1)
Serum Fatty Acid Patterns in Children with Hereditary Motor and Sensory Neuropathies (1979) (1)
Oxidation of Phenolphthalein with Alkaline Hydrogen Peroxide. (1958) (1)
The Effect of Dietetic Treatment on the Serum Lipid Level in Patients with Clinical Signs of Cerebral Arteriosclerosis (1962) (1)
The Breakdown of Adenosine Triphosphate in Human Blood. (1956) (1)
Gangliosides in CSF in autistic children (1994) (1)
Reaction Kinetic Determination of the Hydroxide-Alkoxide Equilibrium in Anion Exchangers. (1958) (1)
Composition of brain ganglio-sides. (1961) (1)
Determination of Glycolipids in Plasma. (1956) (1)
Preparation of Thiotaurine (Aminoethanethiosulfonic Acid). (1958) (1)
Studies on a Thrombin-coagulable Protein in Blood Platelets. (1956) (1)
Gangliosides selectively diminished in early onset Alzheimer's disease (AD type I) suggest synapse loss as primary event (1993) (1)
Examination of the Behavior of Liquid Mixtures in the Critical Region. (1958) (1)
On the Chlorine Content in Human Muscle and Skeletal Tissue. A rectification. (1950) (1)
Contents, Vol. 20, 1976 (1974) (0)
Gangliosides and myelin lipids in senile and presenile dementia (1985) (0)
[Gaucher disease is treatable. Good results with a new form of enzyme substitution]. (1993) (0)
Biological Markers in Alzheimer's Disease (1991) (0)
Enzymic Synthesis of Xanthosine- and Guanosine-5-phosphate. (1956) (0)
The Isolation of a Green Pigment from Yeast. (1958) (0)
The occurrence of III3-alpha-fucosyllactoneotetraosylceramide in human brain. (1980) (0)
CHEMICAL EXAMINATION OF NEURAL BIOPSY MATERIAL (1965) (0)
Gangliosides in Alzheimer’s Disease: Experimental and Clinical Data (1994) (0)
Gangliosides and nerve growth factors in Alzheimer's disease. (1990) (0)
On the Possibility of Periodic Transformations of Enzymes during their Action as Catalysts. (1958) (0)
DETERMINATION OF GM2 IN CULTURED HUMAN GLIOMA, MEDULLOBLASTOMA AND NEUROBLASTOMA CELLS WITH EPITOPE-DEFINED MONOCLONAL ANTIBODIES (MAbs): 165 (1989) (0)
[Mental retardation in children: methods of research laboratory analysis in inherited metabolic defects]. (1980) (0)
Contents, Vol. 4, 1962 (1962) (0)
[Sclerosing leukoencephalitis with a chronic course]. (1968) (0)
New perspectives on virus-host cell receptor interactions as observed with sendai virus (1985) (0)
EXPRESSION OF GD2 BY TUMOR CELL LINES OF NEUROECTODERMAL ORIGIN AND HUMAN GLIOMAS AS DEFINED BY AN EPITOPE-DEFINED ANTI-GD2 MONOCLONAL ANTIBODY: 179 (1990) (0)
GAS CHROMATOGRAPHIC ANALYSIS OF THE FATTY ACID COMPOSITION . OF THE PLASMALIPIDS IN NORMAL AND DIABETIC SUBJECTS (0)
Use of a specific tumor-associated antigens, sialosyllactotetraose, cancer diseases concerning in diagnosis or therapy. (1985) (0)
Sphinolipids of human skeletal muscle. (1972) (0)
Contributors to Volume VI (1972) (0)
Production and Characterization of Two Human Glioma Xenograft-localizing Monoclonal Antibodies 1 (2006) (0)
The ß-Galactosidase — Sialidase Complex (1986) (0)
HUMAN GLIOMA (HGL) XENOGRAFTS AND ESTABLISHED HGL CELL LINES AS ANALYTICAL AND PREPARATIVE SOURCES OF GANGLIOSIDES (1986) (0)
Glangliosides and nerve growth factors Alzheimer's disease (1990) (0)
Seasonal and circadian monoamine variations in human brains examined post mortem. (1980) (0)
[Effects of diet treatment on the serum lipid level in patients with clinical symptoms of cerebral arteriosclerosis]. (1961) (0)
Qantitative estimation of glycolipids in nervous tissue. A methodological study. (1957) (0)
In Honour of Paul Kallós (1987) (0)
Epilepsy in childhood. Biochemical aspects. (1963) (0)
TOXIN ABSORPTION IN CHOLERA (1981) (0)
Contents, Vol. 82, 1987 (1987) (0)
[Fetal diagnosis during the first trimester by transcervical aspiration of chorionic villi]. (1983) (0)
Epilepsy in Childhood: Epilepsy in Childhood. Biochemical Aspects (1963) (0)
Distillation Head for the Distillation of Small Amounts of Liquids. (1958) (0)
Production and Characterization of Two Human Glioma Xenograft-localizing Monoclonal Antibodies1 (2006) (0)
86. CSF from Alzheimer's patients contain antibodies recognizing cholinergic neurons in the rodent CNS (1987) (0)
Diagnostic Possibilities for Inherited Metabolic Diseases (1988) (0)
Subject Index, Vol. 20, 1976 (1976) (0)
Receptor-Specific Large-Scale Purification on Silica Beads Derivatized with LysoGMl of Cholera Toxin Ganglioside (1981) (0)
The Medical Importance of the Research on Lipid Storage Diseases with a Historical Review on the Advances in Gaucher Disease (1988) (0)
Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens. (1992) (0)
NEUROTRANSMITTERS AND RELATED ENZYMES IN NORMAL AGING AND SENILE DEMENTIA (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Lars Svennerholm?

Lars Svennerholm is affiliated with the following schools:

University of Gothenburg

Lars Svennerholm's Academic­Influence.com Rankings

Lars Svennerholm's Degrees

Why Is Lars Svennerholm Influential?

Lars Svennerholm's Published Works

Published Works

What Schools Are Affiliated With Lars Svennerholm?

Lars Svennerholm's AcademicInfluence.com Rankings